These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22393166)

  • 21. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.
    Borroni B; Grassi M; Costanzi C; Zanetti M; Archetti S; Franzoni S; Caimi L; Padovani A
    Neurobiol Aging; 2007 Aug; 28(8):1231-8. PubMed ID: 16837108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
    Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D
    Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of recessive Alzheimer disease loci in a Caribbean Hispanic data set: genome-wide survey of runs of homozygosity.
    Ghani M; Sato C; Lee JH; Reitz C; Moreno D; Mayeux R; St George-Hyslop P; Rogaeva E
    JAMA Neurol; 2013 Oct; 70(10):1261-7. PubMed ID: 23978990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease.
    Ma SL; Tang NL; Tam CW; Lui VW; Lam LC; Chiu HF; Driver JA; Pastorino L; Lu KP
    Neurobiol Aging; 2012 Apr; 33(4):804-13. PubMed ID: 20580132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association study of two steroid biosynthesis genes (COMT and CYP17) with Alzheimer's disease in the Italian population.
    Corbo RM; Gambina G; Broggio E; Scarabino D; Scacchi R
    J Neurol Sci; 2014 Sep; 344(1-2):149-53. PubMed ID: 25012481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of the association between variants in SORL1 and Alzheimer disease.
    Reitz C; Cheng R; Rogaeva E; Lee JH; Tokuhiro S; Zou F; Bettens K; Sleegers K; Tan EK; Kimura R; Shibata N; Arai H; Kamboh MI; Prince JA; Maier W; Riemenschneider M; Owen M; Harold D; Hollingworth P; Cellini E; Sorbi S; Nacmias B; Takeda M; Pericak-Vance MA; Haines JL; Younkin S; Williams J; van Broeckhoven C; Farrer LA; St George-Hyslop PH; Mayeux R;
    Arch Neurol; 2011 Jan; 68(1):99-106. PubMed ID: 21220680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels.
    Reitz C; Cheng R; Schupf N; Lee JH; Mehta PD; Rogaeva E; St George-Hyslop P; Mayeux R
    Neurobiol Aging; 2012 Jan; 33(1):199.e13-7. PubMed ID: 20724036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic determinants of disease progression in Alzheimer's disease.
    Wang X; Lopez OL; Sweet RA; Becker JT; DeKosky ST; Barmada MM; Demirci FY; Kamboh MI
    J Alzheimers Dis; 2015; 43(2):649-55. PubMed ID: 25114068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer's disease.
    Hishimoto A; Pletnikova O; Lang DL; Troncoso JC; Egan JM; Liu QR
    Alzheimers Res Ther; 2019 Mar; 11(1):28. PubMed ID: 30902061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease.
    Chen SY; Chen TF; Lai LC; Chen JH; Sun Y; Wen LL; Yip PK; Chu YM; Chen YC
    J Neuroinflammation; 2012 Jan; 9():21. PubMed ID: 22272811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
    Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
    Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein.
    Zhang C; Browne A; Child D; Divito JR; Stevenson JA; Tanzi RE
    J Biol Chem; 2010 Mar; 285(12):8515-26. PubMed ID: 20097758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
    Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of nerve growth factor receptor (NGFR) and the risk of Alzheimer's disease.
    Cheng HC; Sun Y; Lai LC; Chen SY; Lee WC; Chen JH; Chen TF; Chen HH; Wen LL; Yip PK; Chu YM; Chen WJ; Chen YC
    J Negat Results Biomed; 2012 Jan; 11():5. PubMed ID: 22236693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.
    Caraci F; Bosco P; Signorelli M; Spada RS; Cosentino FI; Toscano G; Bonforte C; Muratore S; Prestianni G; Panerai S; Giambirtone MC; Gulotta E; Romano C; Salluzzo MG; Nicoletti F; Copani A; Drago F; Aguglia E; Ferri R
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):281-9. PubMed ID: 21924590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
    Katzov H; Chalmers K; Palmgren J; Andreasen N; Johansson B; Cairns NJ; Gatz M; Wilcock GK; Love S; Pedersen NL; Brookes AJ; Blennow K; Kehoe PG; Prince JA
    Hum Mutat; 2004 Apr; 23(4):358-67. PubMed ID: 15024730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.